Stigmabase | HIV

FDA ) has approved Tivicay PD (dolutegravir (DTG)), for use in combination with other antiretroviral agents for the treatment of HIV-1 infection ... View article...

... antiretroviral treatment was being contested at the highest levels. Her work later expanded into education, healthcare and other areas of social ... View article...

It builds on the researchers' world-first study published last year, which showed that mRNA could be packaged into nanoparticles and delivered to HIV - ... View article...

... antiretroviral agents in people older than four weeks. Its latest approval is supported by data from the IMPAACT 2023 study, in which HIV-exposed ... View article...

Antiretroviral therapy is received by only 55% of children, whereas among adults, 79% of patients are undergoing treatment. Experts emphasize the ... View article...

While the number of new HIV infections in Hong Kong has declined for 10 consecutive years, the proportion of late presenters among the newly reported ... View article...

This study assessed HIVDR prevalence, patterns and associated factors among individuals on HIV -1 first-line antiretroviral therapy (ART) who were ... View article...

In addition to projections of over a half million potential new HIV infections from persistent disruption, US global health security may be ... View article...